TRANSANTRAL ORBITAL DECOMPRESSION FOR GRAVES-DISEASE

被引:12
作者
TJON, F
SANG, M
NEGT, P
WIJNGAARDE, R
POUBLON, R
VANDERSCHANS, E
KRENNING, E
机构
[1] UNIV HOSP ROTTERDAM,DEPT OTOLARYNGOL,DR MOLEWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS
[2] UNIV HOSP ROTTERDAM,DEPT OPHTHALMOL,ROTTERDAM,NETHERLANDS
[3] UNIV HOSP ROTTERDAM,DEPT NUCL MED & INTERNAL MED,ROTTERDAM,NETHERLANDS
来源
CLINICAL OTOLARYNGOLOGY | 1994年 / 19卷 / 04期
关键词
GRAVES DISEASE; TRANSANTRAL ORBITAL DECOMPRESSION; DYSTHYROID OPHTHALMOPATHY;
D O I
10.1111/j.1365-2273.1994.tb01233.x
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Seventy-five patients with Graves' disease have been treated by transantral orbital decompression. In the first post-operative month the average reduction in proptosis was 3 mm. In the years following the operation this reduction increased to an average of 4.5 mm. In 32% of the patients without diplopia before surgery, the diplopia that developed afterwards did not disappear, 83% of them were successfully treated by extraocular muscle surgery. Seventy per cent of the patients experienced immediate post-operative improvement of visual acuity. Only three patients remained with anaesthesia of the infra-orbital nerve. A total of 65% of the patients found the operation procedure beneficial while 76% were satisfied with the ophthalmological result. We conclude, that transantral orbital decompression, though with moderate morbidity, gives good results in patients with the orbital complications of Graves' disease.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 50 条
  • [31] INCREASED SERUM NEOPTERIN LEVELS IN PATIENTS WITH GRAVES-DISEASE
    WAGNER, R
    HAYATGHEBI, S
    ROSENKRANZ, M
    REINWEIN, D
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1993, 101 (04): : 249 - 254
  • [32] SEIZURE THRESHOLD IN JUVENILE MYOCLONIC EPILEPSY WITH GRAVES-DISEASE
    SU, YH
    IZUMI, T
    KITSU, M
    FUKUYAMA, Y
    EPILEPSIA, 1993, 34 (03) : 488 - 492
  • [33] THE OUTCOME OF PATIENTS WITH THYROID-CARCINOMA AND GRAVES-DISEASE
    KASUGA, Y
    SUGENOYA, A
    KOBAYASHI, S
    MASUDA, H
    IIDA, F
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1993, 23 (01): : 9 - 12
  • [34] ACTIVATION OF BLOOD-COAGULATION AND FIBRINOLYSIS IN GRAVES-DISEASE
    MARONGIU, F
    CONTI, M
    MURTAS, ML
    MAMELI, G
    SORANO, GG
    MARTINO, E
    HORMONE AND METABOLIC RESEARCH, 1991, 23 (12) : 609 - 611
  • [35] LITHIUM-CARBONATE IN THE PREOPERATIVE PREPARATION OF GRAVES-DISEASE
    TSUNODA, T
    MOCHINAGA, N
    ETO, T
    YAMAGUCHI, M
    TSUCHIYA, R
    IZUMI, M
    JAPANESE JOURNAL OF SURGERY, 1991, 21 (03): : 292 - 296
  • [36] INCIDENTAL PRESENCE OF ANTIBODIES AGAINST GANGLIOSIDES IN GRAVES-DISEASE
    ADLER, G
    PACUSZKA, T
    TARGONSKA, I
    LEWARTOWSKA, A
    NAUMAN, J
    AUTOIMMUNITY, 1994, 18 (02) : 149 - 152
  • [37] NEONATAL THYROTOXICOSIS IN A NEONATE OF A MOTHER WITH ASYMPTOMATIC GRAVES-DISEASE
    PETER, M
    SIPPELL, WG
    MONATSSCHRIFT KINDERHEILKUNDE, 1995, 143 (01) : 28 - 30
  • [38] BILE-ACID MALABSORPTION ASSOCIATED WITH GRAVES-DISEASE
    RAJU, GS
    DAWSON, B
    BARDHAN, KD
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1994, 19 (01) : 54 - 56
  • [39] THYROTOXIC CRISIS IN GRAVES-DISEASE - INDICATION FOR IMMEDIATE SURGERY
    SCHAAF, L
    GRESCHNER, M
    PASCHKE, R
    KUSTERER, K
    TEUBER, J
    HUCK, K
    SCHMIDT, R
    SAGER, HD
    USADEL, KH
    KLINISCHE WOCHENSCHRIFT, 1990, 68 (21): : 1037 - 1041
  • [40] HUMAN LYMPHOCYTE ANTIGENS (HLA) AND GRAVES-DISEASE IN TURKEY
    ORHAN, Y
    AZEZLI, A
    CARIN, M
    ARAL, F
    SENCER, E
    MOLVALILAR, S
    JOURNAL OF CLINICAL IMMUNOLOGY, 1993, 13 (05) : 339 - 343